Ethnic variations in the prevalence of diabetic retinopathy in people with diabetes attending screening in the United Kingdom (DRIVE UK)

PLoS ONE

Volumn 7, Issue 3, 2012, Pages

  Sivaprasad, Sobha ^a   Gupta, Bhaskar ^a   Gulliford, Martin C ^b   Dodhia, Hiten ^c   Mohamed, Moin ^d   Nagi, Dinesh ^e   Evans, Jennifer R ^f  

^a KING'S COLLEGE HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c Lambeth NHS Primary Care Trust   (United Kingdom)

^d ST THOMAS HOSPITAL   (United Kingdom)

^e MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AFRICAN CARIBBEAN; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN; BIOMICROSCOPY; CAUCASIAN; COHORT ANALYSIS; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC RETINOPATHY; DISEASE CLASSIFICATION; DISEASE PREDISPOSITION; ETHNIC DIFFERENCE; ETHNICITY; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; LASER COAGULATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; RACE DIFFERENCE; RETINA MACULOPATHY; SCREENING; SEX DIFFERENCE; UNITED KINGDOM; VISUAL ACUITY; VISUAL IMPAIRMENT; ADOLESCENT; ETHNOLOGY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; GREAT BRITAIN; HUMANS; MALE; MIDDLE AGED; PREVALENCE; YOUNG ADULT;

EID: 84857848357     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0032182     Document Type: Article

References (21)

1. PKC-DRS Study Group (2005) The effect of ruboxistaurin on visual loss in patients with moderately severe to very severe nonproliferative diabetic retinopathy: initial results of the Protein Kinase C beta Inhibitor Diabetic Retinopathy Study (PKC-DRS) multicenter randomized clinical trial. Diabetes 54: 2188-97.
2. Diabetes UK, (2010) Diabetes in the UK 2010: key statistics on diabetes. Available:www.diabetes.org.uk/Documents/Reports/Diabetes_in_the_UK_2010.pdf. Accessed 2011 Aug 11.
3. Yorkshire and the Humber Quality Observatory (YHQO) (2011) APHO Diabetes Prevalence Model for England. Avaialble: www.yhpho.org.uk. Accessed 2011 Aug 11.
4. Kempen JH, O'Colmain BJ, Leske MC, Haffner SM, Klein R, et al. (2004) The prevalence of diabetic retinopathy among adults in the United States. Arch Ophthalmol 122: 552-63.
5. Wong TY, Klein R, Islam FM, Cotch MF, Folsom AR, et al. (2006) Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol 141: 446-55.
6. Garvican L, Scanlon P, (2003) Quality Assurance for the National Screening Programme for Sight-threatening Diabetic Retinopathy: Development of a Set of Key Quality Assurance Standards. Available: www.retinalscreening.nhs.uk. Accessed 2011 Aug 11.
7. UK National Screening Committee (2007) Essential elements in developing a diabetic retinopathy screening programme, Workbook 4. Available: www.retinalscreening.nhs.uk. Accessed 2011 Aug 11.
8. Early Treatment Diabetic Retinopathy Study Research Group (1991) Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98: 786-806.
9. Wilkinson CP, Ferris FL 3rd, Klein RE, Lee PP, Agardh CD, et al. (2003) Proposed international clinical diabetic retinopathy and diabetic macular edema disease severity scales. Ophthalmology 110: 1677-82.
10. Heintz E, Wirehn AB, Peebo BB, Rosenqvist U, Levin LA, (2010) Prevalence and healthcare costs of diabetic retinopathy: a population-based register study in Sweden. Diabetologia 53: 2147-54.
11. Bojestig M, Arnqvist HJ, Karlberg BE, Ludvigsson J, (1998) Unchanged incidence of severe retinopathy in a population of Type 1 diabetic patients with marked reduction of nephropathy. Diabet Med 15: 863-9.
12. Hovind P, Tarnow L, Rossing K, Rossing P, Eising S, et al. (2003) Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26: 1258-64.
13. Raymond NT, Varadhan L, Reynold DR, Bush K, Sankaranarayanan S, et al. (2009) Higher prevalence of retinopathy in diabetic patients of South Asian ethnicity compared with white Europeans in the community: a cross-sectional study. Diabetes Care 32: 410-5.
14. Younis N, Broadbent DM, Vora JP, Harding SP, (2003) Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: a cohort study. Lancet 361: 195-200.
15. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-53.
16. Chaturvedi N, Jarrett J, Morrish N, Keen H, Fuller JH, (1996) Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study. BMJ 313: 848-52.
17. Cruickshank JK, Alleyne SA, (1987) Black West Indian and matched White diabetics in Britain compared with diabetics in Jamaica: body mass, blood pressure, and vascular disease. Diabetes Care 10: 170-9.
18. Emanuele N, Sacks J, Klein R, Reda D, Anderson R, et al. (2005) Ethnicity, race, and baseline retinopathy correlates in the veterans affairs diabetes trial. Diabetes Care 28: 1954-8.
19. Klein R, Sharrett AR, Klein BE, Moss SE, Folsom AR, et al. (2002) The association of atherosclerosis, vascular risk factors, and retinopathy in adults with diabetes: the atherosclerosis risk in communities study. Ophthalmology 109: 1225-34.
20. Klein R, Marino EK, Kuller LH, Polak JF, Tracy RP, et al. (2002) The relation of atherosclerotic cardiovascular disease to retinopathy in people with diabetes in the Cardiovascular Health Study. Br J Ophthalmol 86: 84-90.
21. Zhang X, Saaddine JB, Chou CF, Cotch MF, Cheng YJ, et al. (2010) Prevalence of diabetic retinopathy in the United States, 2005-2008. JAMA 304: 649-56.